$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Controlled release formulations coated with aqueous dispersions of acrylic polymers 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/32
출원번호 US-0097558 (1993-07-27)
발명자 / 주소
  • Oshlack Benjamin (New York NY) Pedi
  • Jr. Frank (Yorktown Heights NY) Chasin Mark (Manalapan NJ)
출원인 / 주소
  • Euro-Celtique, S.A. (LUX 03)
인용정보 피인용 횟수 : 326  인용 특허 : 0

초록

A stable solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic acrylic polymer includes a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic agent, a disin

대표청구항

A controlled release formulation comprising a substrate containing an active agent in an amount sufficient to provide a desired effect in an environment of use, said substrate coated with a plasticized aqueous dispersion consisting essentially of ammoniomethacrylate copolymers which are copolymeriza

이 특허를 인용한 특허 (326)

  1. Habib, Walid A.; Hamed, Ehab; Vega Zepeda, Manuel A., Abuse resistant drug formulation.
  2. Habib, Walid A.; Hamed, Ehab; Vega Zepeda, Manuel A., Abuse resistant drug formulation.
  3. Habib, Walid A.; Hamed, Ehab; Vega Zepeda, Manuel A., Abuse resistant drug formulation.
  4. Habib, Walid; Hamed, Ehab; Moe, Derek; Kraling, Carrie; Hillman, Lisa, Abuse resistant drug formulation.
  5. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  6. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  7. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  8. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  9. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  10. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  11. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  12. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  13. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  14. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  15. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  16. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  17. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  18. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  19. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  20. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  21. Hamed, Ehab, Alcohol-resistant metoprolol-containing extended-release oral dosage forms.
  22. Burch, Ronald M.; Goldenheim, Paul D.; Sackler, Richard S., Analgesic combination of oxycodone and N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl] methanesulfonamide.
  23. Burch, Ronald M.; Goldenheim, Paul D.; Sackler, Richard S., Analgesic combination of oxycodone and celecoxib.
  24. Burch, Ronald M.; Sackler, Richard S.; Goldenheim, Paul D., Analgesic combination of oxycodone and meloxicam.
  25. Burch, Ronald M.; Sackler, Richard S; Goldenheim, Paul D, Analgesic combination of oxycodone and nimesulide.
  26. Burch, Ronald M.; Goldenheim, Paul D.; Sackler, Richard S., Analgesic combination of tramadol and meloxicam.
  27. Sangekar Surendra A. ; Vadino Winston A. ; Lee Ping I., Antifungal composition with enhanced bioavailability.
  28. Fuisz, Richard C.; Fuisz, Joseph M., Bioactive dose having containing a material for modulating pH of a bodily fluid to help or hinder absorption of a bioactive.
  29. Mehta, Ketan; Tu, Yu-Hsing, Clonidine formulation.
  30. Li, Jian-Xin; Carlin, Brian A. C., Coating process to produce controlled release coatings.
  31. Von Coburg, Yvonne; Reimer, Karen; Oksche, Alexander; Holzer, Peter, Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation.
  32. Zebala, John A., Compositions for overcoming resistance to tramadol.
  33. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  34. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  35. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  36. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  37. Leung, Karling Alice, Compositions, devices and methods of use thereof for the treatment of cancers.
  38. Dihora, Jiten Odhavji; Hasegawa, Jun, Conditioner compositions with increased deposition of polyacrylate microcapsules.
  39. Dihora, Jlten Odhavji; Hasegawa, Jun, Conditioner compositions with increased deposition of polyacrylate microcapsules.
  40. Geiger, Albert J.; Stelmack, Eugene G.; Babiak, Nicolette M., Controlled release fertilizer and method for production thereof.
  41. Oshlack,Benjamin; Chasin,Mark; Pedi, Jr.,Frank, Controlled release formulations coated with aqueous dispersions of acrylic polymers.
  42. Krishnamurthy, Thinnayam N.; Darke, Andrew, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
  43. Krishnamurthy, Thinnayam N.; Darke, Andrew, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
  44. Krishnamurthy, Thinnayam N.; Darke, Andrew, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
  45. Krishnamurthy,Thinnayam N.; Darke,Andrew, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
  46. Krishnamurthy,Thinnayam N.; Darke,Andrew, Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations.
  47. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  48. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  49. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  50. Oshlack, Benjamin; Huang, Hua Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  51. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  52. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  53. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  54. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  55. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  56. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  57. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  58. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  59. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  60. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  61. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  62. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  63. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  64. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  65. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  66. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  67. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Controlled release hydrocodone formulations.
  68. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  69. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  70. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  71. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  72. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  73. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  74. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  75. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  76. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  77. Oshlack, Benjamin; Masselink, John K.; Huang, Hua-Pin; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  78. Sriwongjanya Mongkol ; Weng Timothy ; Chou Joseph ; Chen Chih-Ming, Controlled release oral dosage form.
  79. Miller,Ronald Brown; Malkowska,Sandra Therese Antoinette; Wimmer,Walter; Hahn,Udo; Leslie,Stewart Thomas; Smith,Kevin John; Winkler,Horst; Prater,Derek Allan, Controlled release tramadol tramadol formulation.
  80. Lenaerts, Vincent; Ouadji-Njiki, Patricia Laure; Bacon, Johnatan; Ouzerourou, Rachid; Gervais, Sonia; Rahmouni, Miloud; Smith, Damon, Controlled-release compositions.
  81. Goldenheim, Paul D.; Sackler, Richard S.; Krishnamurthy, Thinnayam N.; Darke, Andrew; Oshlack, Benjamin, Controlled/modified release oral methylphenidate formulations.
  82. Goldenheim,Paul D.; Sackler,Richard S.; Krishnamurthy,Thinnayam N.; Darke,Andrew; Oshlaci,Benjamin, Controlled/modified release oral methylphenidate formulations.
  83. Mehta, Atul M.; Zeitlin, Andrew L.; Dariani, Maghsoud M., Delivery of multiple doses of medications.
  84. Mehta,Atul M.; Zeitlin,Andrew L.; Dariani,Maghsoud M., Delivery of multiple doses of medications.
  85. Dihora, Jiten Odhavji; Smets, Johan; Schwantes, Todd Arlin, Delivery particle.
  86. Dihora, Jiten Odhavji; Smets, Johan; Schwantes, Todd Arlin, Delivery particles.
  87. Ruppert, Klaus; Renz, Karl-Heinz; Vogt, Sebastian, Dental materials equipped with active anti-plaque substance(s).
  88. Alessi, Thomas R.; Leung, Karling Alice; Mercer, Ryan D.; Negulescu, Cristina G.; Rohloff, Catherine M.; Yang, Bing, Devices, formulations, and methods for delivery of multiple beneficial agents.
  89. Conrad, John H.; Payne, Patrick, Elastic laminates having fragrance releasing properties and methods of making the same.
  90. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  91. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  92. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  93. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  94. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  95. Huang, Haiyong Hugh, Encased tamper resistant controlled release dosage forms.
  96. Leung,Sau Hung Spence; Leone,Robert S.; Kumar,Lori D.; Kulkarni,Neema; Sorg,Albert F., Fast dissolving orally consumable films.
  97. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  98. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  99. Benjamin Oshlack ; Mark Chasin, Immediate release tablet cores of insoluble drugs having sustained-release coating.
  100. Oshlack Benjamin ; Chasin Mark, Immediate release tablet cores of insoluble drugs having sustained-release coating.
  101. Smith, Jay S.; Cole, Michael R.; Whitson, Amy K., Implant placement guide.
  102. Smith, Jay S.; Cole, Michael R.; Whitson, Amy K., Implant placement guide.
  103. Patel, Rajesh A.; Bucalo, Louis R.; Costantini, Lauren; Kleppner, Sofie, Implantable polymeric device for sustained release of dopamine agonist.
  104. Patel, Rajesh A.; Bucalo, Louis R.; Costantini, Lauren; Kleppner, Sofie, Implantable polymeric device for sustained release of dopamine agonist.
  105. Clarke, Allan J.; Glinecke, Robert; Raby, Ronald; Li, Chi Leung; Martini, Luigi, Injection molding process for the preparation of an oral delivery device for a pharmaceutically active agent.
  106. Clarke, Allan J.; Glinecke, Robert; Raby, Ronald; Li, Chi Leung; Martini, Luigi, Injection molding process for the preparation of an oral delivery device for the pharmaceutically active agent.
  107. Brögmann, Bianca; Muhlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  108. Brögmann, Bianca; Mühlah, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  109. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  110. Leyendecker, Petra; Hopp, Michael; Drews, Axel, Method and device for the assessment of bowel function.
  111. Brown, Douglas S.; Smith, Jeffrey A., Method of manufacture air freshening article.
  112. Sackler Richard ; Kaiko Robert ; Goldenheim Paul, Method of treating humans with opioid formulations having extended controlled release.
  113. Sackler, Richard; Kaiko, Robert; Goldenheim, Paul, Method of treating humans with opioid formulations having extended controlled release.
  114. Vargas Rincon, Ricardo Alberto; Reiz, Joseph, Methods and compositions particularly for treatment of attention deficit disorder.
  115. Vargas Rincon, Ricardo Alberto; Reiz, Joseph, Methods and compositions particularly for treatment of attention deficit disorder.
  116. Zebala, John A., Methods for overcoming resistance to tramadol.
  117. Zebala, John A., Methods for overcoming resistance to tramadol.
  118. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of manufacturing oral dosage forms.
  119. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of manufacturing oral formulations.
  120. Eliaz, Rom Ezer; Zhang, Yuanpeng; Rohloff, Catherine Manya; Weeks, Eric William; Junnarkar, Gunjan, Methods of manufacturing viscous liquid pharmaceutical formulations.
  121. Krishnamurthy, Thinnayam N.; Darke, Andrew, Methods of preparing oral controlled release formulations.
  122. Guido, Debora; Huang, Haiyong Hugh, Methods of preparing tamper resistant pharmaceutical formulations.
  123. Sackler, Richard S., Methods of preparing tamper resistant solid oral dosage forms.
  124. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of providing analgesia.
  125. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of providing analgesia.
  126. Krishnamurthy, Thinnayam N.; Darke, Andrew, Methods of treating attention deficit hyperactivity disorder.
  127. Krishnamurthy, Thinnayam N.; Darke, Andrew, Methods of treating attention deficit hyperactivity disorder.
  128. Lautenbach,Scott D., Minimally compliant, volume-efficient piston for osmotic drug delivery systems.
  129. Bezuidenhout, Deon; Theron, Jacobus P.; Higham, Lawrence J.; Zilla, Peter P., Modification of thermoplastic polymers.
  130. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug - ion exchange resin complexes.
  131. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  132. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  133. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  134. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  135. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  136. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  137. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  138. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  139. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  140. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  141. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  142. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  143. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug-ion exchange resin complexes.
  144. Mehta, Ketan; Tu, Yu-Hsing, Modified release formulations containing drug—ion exchange resin complexes.
  145. Stark, Paul; Kelly, Catherine Mary; Fanning, Niall M., Multiparticulate bisoprolol formulation.
  146. Hayes, Geoffrey Gerard; Martinelli, Vincenzo; Mohammad, Hassan; Tamber, Harjit; Walden, Malcolm; Whitelock, Steve, Multiparticulates.
  147. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Once-A day oxycodone formulations.
  148. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Once-a-day oxycodone formulations.
  149. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Once-a-day oxycodone formulations.
  150. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  151. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  152. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  153. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  154. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  155. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  156. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  157. Wimmer, Walter; Brogmann, Bianca; Hahn, Udo; Spitzley, Christof, Opioid analgesic.
  158. Wright, Curtis; Colucci, Robert; El-Tahtawy, Ahmed, Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose Cmax.
  159. Wright, Curtis; Colucci, Robert; El-Tahtawy, Ahmed, Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose Cmax.
  160. Chasin Mark ; Oshlack Benjamin ; Pedi ; Jr. Frank, Opioid formulations having extended controlled release.
  161. Chasin Mark ; Oshlack Benjamin ; Pedi ; Jr. Frank, Opioid formulations having extended controlled released.
  162. Evenstad, Kenneth L.; Wertz, Christian F.; Jensen, James S.; O'Neill, Victoria Ann; Berge, Stephen M., Opioid-containing oral pharmaceutical compositions and methods.
  163. Evenstad, Kenneth L.; Wertz, Christian F.; Jensen, James S.; O'Neill, Victoria Ann; Berge, Stephen M., Opioid-containing oral pharmaceutical compositions and methods.
  164. Fleischer, Wolfgang; Reimer, Karen; Leyendecker, Petra, Opioids for the treatment of the chronic obstructive pulmonary disease (COPD).
  165. Wright, IV, Curtis; Carpanzano, Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  166. Wright, IV,Curtis; Carpanzano,Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  167. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  168. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  169. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  170. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  171. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  172. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharamaceutical dosage forms.
  173. Scicinski, Jan J.; van Osdol, William W.; Su, Huey-Ching; Arenberg, Michael H.; Shah, Jaymin, Oral pharmaceutical dosage forms.
  174. Scicinski, Jan J.; van Osdol, William W.; Su, Huey-Ching; Arenberg, Michael H.; Shah, Jaymin, Oral pharmaceutical dosage forms.
  175. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  176. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  177. Oshlack Benjamin ; Chasin Mark, Orally administrable opioid formulations having extended duration of effect.
  178. Oshlack Benjamin ; Chasin Mark, Orally administrable opioid formulations having extended duration of effect.
  179. Oshlack, Benjamin; Chasin, Mark, Orally administrable opioid formulations having extended duration of effect.
  180. Oshlack,Benjamin; Chasin,Mark, Orally administrable opioid formulations having extended duration of effect.
  181. Alessi, Thomas R.; Mercer, Ryan D.; Rohloff, Catherine M.; Yang, Bing, Osmotic delivery device comprising an insulinotropic peptide and uses thereof.
  182. Oshlack, Benjamin; Wright, Curtis; Prater, Derek, Oxycodone formulations.
  183. Kao, Haui-Hung; Baichwal, Anand R.; McCall, Troy; Lee, David, Oxymorphone controlled release formulations.
  184. Kao, Huai-Hung; Baichwal, Anand R.; McCall, Troy; Lee, David, Oxymorphone controlled release formulations.
  185. Dihora, Jiten Odhavji; Brown, Mark Anthony, Personal cleansing compositions with increased deposition of polyacrylate microcapsules.
  186. Liang, Alfred; Matthews, Frank; Boehm, Garth; Tang, Lijuan; Johnson, Frank; Stauffer, Joseph, Pharmaceutical composition.
  187. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical composition.
  188. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical composition containing gelling agent.
  189. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions.
  190. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions for the deterrence and/or prevention of abuse.
  191. Dittmar, Gregory Paul; Amante, Joseph Michael; Cronk, Tony Ryan; Newby, Daniel Gary, Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures.
  192. Dittmar, Gregory Paul; Amante, Joseph Michael; Cronk, Tony Ryan; Newby, Daniel Gary, Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures.
  193. Dittmar, Gregory Paul; Amante, Joseph Michael; Cronk, Tony Ryan; Newby, Daniel Gary, Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures.
  194. Miller, Ronald Brown; Leslie, Stewart Thomas; Malkowska, Sandra Therese Antoinette; Prater, Derek Allan; Knott, Trevor John; Mohammad, Hassan, Pharmaceutical formulation.
  195. Ronald Brown Miller CH; Stewart Thomas Leslie GB; Sandra Therese Antoinette Malkowska GB; Derek Allan Prater GB; Trevor John Knott GB; Hassan Mohammad GB, Pharmaceutical formulation.
  196. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  197. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  198. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  199. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  200. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  201. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  202. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  203. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  204. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  205. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  206. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  207. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  208. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  209. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  210. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  211. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  212. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  213. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  214. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  215. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  216. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  217. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  218. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  219. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  220. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  221. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  222. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  223. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  224. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  225. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  226. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  227. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  228. Wright, Curtis; Oshlack, Benjamin; Breder, Christopher, Pharmaceutical formulation containing gelling agent.
  229. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  230. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  231. Khetani,Vikram; Luo,Yalin; Ramaswamy,Sowmianarayanan, Processes and intermediates for resolving piperidyl acetamide stereoisomers.
  232. Dansereau, Richard John; Anness, Daren K.; Ramsey, David L.; Balan, Guhan, Pulsed release phenylephrine dosage forms.
  233. Alessi, Thomas R.; Luskey, Kenneth, Rapid establishment and/or termination of substantial steady-state drug delivery.
  234. Sen, Himadri; Kshirsagar, Rajesh Suresh; Menjoge, Anupa Ramesh, Rapidly disintegrating sustained release cefuroxime axetil composition.
  235. Brown, Douglas S.; Smith, Jeffrey A., Replaceable restroom urinal assemblies, including urinal screens.
  236. Jelonek, Paul Richard; Bernardo, Emani, Reversible color-changing ink formulations and nonwoven wipes.
  237. Jelonek, Paul Richard; Bernardo, Ernani, Reversible color-changing ink formulations and nonwoven wipes.
  238. Farrugia, Darren J.; Ward, Lesley J.; Reichert, Veronica R., Reversible color-changing sanitizer-indicating nonwoven wipe.
  239. Farrugia, Darren J.; Ward, Lesley J.; Reichert, Veronica R., Reversible color-changing sanitizer-indicating nonwoven wipe.
  240. Farrugia, Darren J.; Ward, Lesley J.; Reichert, Veronica R., Reversible color-changing sanitizer-indicating nonwoven wipe.
  241. Boehm, Garth, Sequestering subunit and related compositions and methods.
  242. Boehm, Garth, Sequestering subunit and related compositions and methods.
  243. Boehm, Garth, Sequestering subunit and related compositions and methods.
  244. Dihora, Jiten Odhavji; Brown, Mark Anthony, Shampoo compositions with increased deposition of polyacrylate microcapsules.
  245. Dihora, Jiten Odhavji; Brown, Mark Anthony, Shampoo compositions with increased deposition of polyacrylate microcapsules.
  246. Pawan Seth, Solid compositions containing glipizide and polyethylene oxide.
  247. Narayanan Kolazi S., Soluble polymer based matrix for chemically active water insoluble components.
  248. Rohloff, Catherine M.; Chen, Guohua; Luk, Andrew S.; Ayer, Rupal A.; Houston, Paul R.; Desjardin, Michael A.; Zamora, Pauline; Lam, Stan, Solvent/polymer solutions as suspension vehicles.
  249. Oshlack Benjamin ; Chasin Mark ; Pedi ; Jr. Frank, Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer.
  250. Oshlack, Benjamin; Chasin, Mark; Pedi, Jr., Frank, Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer.
  251. Oshlack,Benjamin; Chasin,Mark; Pedi, Jr.,Frank, Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer.
  252. Oshlack Benjamin ; Huang Hua-Pin ; Chasin Mark ; Goldenheim Paul, Stabilized sustained release tramadol formulations.
  253. Oshlack, Benjamin; Huang, Hua-Pin; Chasin, Mark; Goldenheim, Paul, Stabilized sustained release tramadol formulations.
  254. Miller Ronald Brown,CHX ; Leslie Stewart Thomas,GBX ; Malkowska Sandra Therese Antoinette,GBX ; Prater Derek Allan,GBX ; Knott Trevor John,GBX ; Heafield Joanne,GBX ; Challis Deborah,GBX, Substained release compositions and a method of preparing pharmaceutical compositions.
  255. Gervais, Sonia; Smith, Damon; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh, Sustained drug release composition.
  256. Gervais, Sonia; Smith, Damon; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh, Sustained drug release composition.
  257. Gervais, Sonia; Smith, Damon; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh, Sustained drug release compositions.
  258. Pawan Seth, Sustained release carbamazepine pharmaceutical composition free of food effect and a method for alleviating food effect in drug release.
  259. Heafield Joanne,GBX ; Knott Trevor John,GBX ; Leslie Stewart Thomas,GBX ; Malkowska Sandra Therese Antoinette,GBX ; Miller Ronald Brown,CHX ; Prater Derek Allan,GBX ; Smith Kevin John,GBX, Sustained release compositions and a method of preparing pharmaceutical compositions.
  260. Miller Ronald Brown,CHX ; Leslie Stewart Thomas,GBX ; Malkowska Sandra Therese Antoinette,GBX ; Prater Derek Allan,GBX ; Knott Trevor John,GBX ; Heafield Joanne,GBX ; Challis Deborah,GBX, Sustained release compositions and a method of preparing pharmaceutical compositions.
  261. Heafield Joanne,GB2 ; Knott Trevor John,GB2 ; Leslie Stewart Thomas,GB2 ; Malkowska Sandra Therese Antoinette,GB2 ; Miller Ronald Brown,CHX ; Prater Derek Allan,GB2 ; Smith Kevin John,GB2, Sustained release compositions of morphine and a method of preparing pharmaceutical compositions.
  262. Baichwal,Anand R.; Kao,Huai Hung; McCall,Troy W., Sustained release formulations of oxymorphone.
  263. Pawan Seth, Sustained release pharmaceutical composition free of food effect.
  264. Wertz, Christian F.; Jensen, James S.; O'Neill, Victoria Ann; Mahoney, Sean B.; Berge, Stephen M., Sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug.
  265. Lenaerts, Vincent; Ouadji-Nijki, Patricia Laure; Bacon, Jonathan; Ouzérourou, Rachid; Gervais, Sonia; Rahmouni, Miloud; Smith, Damon, Sustained-release tramadol formulations with 24-hour efficacy.
  266. Wertz, Christian F.; Jensen, James S.; O'Neill, Victoria Ann; Mahoney, Sean B.; Berge, Stephen M., Sustained-released product comprising a combination of a non-opioid amine and a non-steroidal, anti-inflammatory drug.
  267. Benoit,Didier; Safir,Adam; Chang,Han Ting; Charmot,Dominique; Okamoto,Kenji; Nishimura,Isao; Wang,Yong, Synthesis of photoresist polymers.
  268. Hummel, Michele; Kyle, Donald J.; Whiteside, Garth, Systems and methods for treating an opioid-induced adverse pharmacodynamic response.
  269. Hummel, Michele; Kyle, Donald J.; Whiteside, Garth, Systems and methods for treating an opioid-induced adverse pharmacodynamic response.
  270. Hummel, Michele; Kyle, Donald J.; Whiteside, Garth, Systems and methods for treating an opioid-induced adverse pharmacodynamic response.
  271. Hummel, Michele; Kyle, Donald J.; Whiteside, Garth, Systems and methods for treating an opioid-induced adverse pharmacodynamic response.
  272. Hummel, Michele; Kyle, Donald J.; Whiteside, Garth, Systems and methods for treating an opioid-induced adverse pharmacodynamic response.
  273. Hummel, Michele; Kyle, Donald J.; Whiteside, Garth, Systems and methods for treating an opioid-induced adverse pharmacodynamic response.
  274. Hummel, Michelle; Kyle, Donald J.; Whiteside, Garth, Systems and methods for treating an opioid-induced adverse pharmacodynamic response.
  275. Hummel, Michele; Kyle, Donald J.; Whiteside, Garth, Systems for treating an opioid-induced adverse pharmacodynamic response.
  276. Huang, Haiyong Hugh, Tamper resistant controlled release dosage forms.
  277. Huang, Haiyong Hugh, Tamper resistant controlled release dosage forms.
  278. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  279. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  280. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  281. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  282. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  283. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  284. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  285. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  286. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  287. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  288. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  289. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  290. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  291. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  292. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  293. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  294. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  295. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  296. McKenna, William H.; Mannion, Richard O.; O'Donnell, Edward P.; Huang, Haiyong H., Tamper resistant dosage forms.
  297. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper resistant oral opioid agonist formulations.
  298. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  299. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  300. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  301. Guido, Debora; Huang, Haiyong Hugh, Tamper resistant pharmaceutical formulations.
  302. Shmeis, Rama Abu; Muley, Sheetal R.; Shen, Xiaohong; Zong, Zhixin, Tamper resistant pharmaceutical formulations.
  303. Shmeis, Rama Abu; Muley, Sheetal R.; Shen, Xiaohong; Zong, Zhixin, Tamper resistant pharmaceutical formulations.
  304. Sackler, Richard S., Tamper resistant solid oral dosage forms.
  305. Sackler, Richard S., Tamper resistant solid oral dosage forms.
  306. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  307. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  308. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  309. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  310. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  311. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  312. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  313. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  314. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  315. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  316. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  317. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  318. Mukherji, Gour; Goel, Sandhya; Arora, Vinod Kumar, Taste masked compositions.
  319. Appel, Leah Elizabeth; Friesen, Dwayne Thomas; LaChapelle, Edward Dennis; Konagurthu, Sanjay; Falk, Richard Frank; Reo, Joseph P., Taste-masked drugs in rupturing multiparticulates.
  320. Alessi, Thomas R.; Baron, Michelle, Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c.
  321. Gervais, Sonia; Smith, Damon; Rahmouni, Miloud; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh; Ferrada, Angela; Soulhi, Fouzia, Trazodone composition for once a day administration.
  322. Gervais, Sonia; Smith, Damon; Rahmouni, Miloud; Contamin, Pauline; Ouzerourou, Rachid; Ma, My Linh; Ferrada, Angela; Soulhi, Fouzia, Trazodone composition for once a day administration.
  323. Lautenbach, Scott C.; De La Serna, Pedro E.; Zamora, Pauline C.; Desjardin, Michael A., Two-piece, internal-channel osmotic delivery system flow modulator.
  324. Brown, Douglas S.; Smith, Jeffrey A., Urinal screen.
  325. Brown, Douglas S.; Smith, Jeffrey A., Urinal screen.
  326. Brown, Douglas S.; Smith, Jeffrey A., Urinal screens.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로